Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 5Carcinoma, Squamous Cell 2Squamous Intraepithelial Lesions 1Radiodermatitis 1Psoriasis 1Neoplasms 1Lymphoma, Follicular 1Carcinoma 1Breast Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × calcipotriene × Clear all
NCT00445250 2007-03-08

The Role of Calcipotriol as Radioprotector of Skin

Rabin Medical Center

Phase 2 Unknown
50 enrolled

Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡